New Delhi: Two indigenous Indian candidate vaccines have got clearance to start early phase human trials this month with both having approximately 1,000 human volunteers each, the Indian Council of Medical Research (ICMR) said on Tuesday. 

Speaking a media briefing of the Ministry of Health and Family Welfare on COVID-19 situation in the country, Balram Bhargava, DG, ICMR said 60% of the vaccines supplied in the world are of Indian origin. 

India is perceived and is an important player in the global vaccine supply, fast-tracking COVID-19 vaccine development is a moral duty, Bhargava said.